HEAL.L
iShares Healthcare Innovation UCITS ETF
Global
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 986.7 M
ASSETS UNDER MGMT
40 bp
EXPENSES
Fund Basics
| Inception date | Sep 08, 2016 |
| Regulation | UCITS |
| ISIN | IE00BYZK4776 |
| Distributions | |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
| ILLUMINA INC | 2.5 % |
| MODERNA, INC. | 2.3 % |
| UCB SA | 2.3 % |
| JOHNSON & JOHNSON | 2.3 % |
| BIOGEN IDEC INC | 2.2 % |
| MERCK & CO. INC. | 2.2 % |
| NATERA INC | 2.0 % |
| GSK PLC | 1.9 % |
| NOVARTIS AG | 1.9 % |
| GILEAD SCIENCES INC | 1.9 % |
Constituent Breakdown
| Number of holdings | 197 |
| Herfindahl-Hirschman Index | 127 |
| Wgt avg mkt cap (mns) | $64,658 |
| Large cap (>$10bn) | 65.9% |
| Mid cap ($2-10bn) | 21.1% |
| Small cap (<$2bn) | 7.1% |
| Developed mkts. | 85.1% |
| Emerging mkts. | 6.7% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 62.9 % |
 |
SOUTH KOREA | 4.1 % |
 |
SWITZERLAND | 4.0 % |
 |
JAPAN | 3.8 % |
 |
CHINA | 2.5 % |
 |
BRITAIN | 2.5 % |
 |
BELGIUM | 2.4 % |
 |
DENMARK | 2.3 % |
 |
IRELAND | 2.1 % |
 |
FRANCE | 1.5 % |
Historical Performance
Standardized Performance (as of 05/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -0.4% | 21.2% | 10.2% | 7.0% | -2.3% | -- | -- | 6.4% |
| Dividend Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -- | -- | 0.0% |
| Total Returns | -0.4% | 21.2% | 10.2% | 7.0% | -2.3% | -- | -- | 6.4% | Ann. Volatility | 19.5% | 17.1% | 17.7% | 17.1% | 19.8% | -- | -- | 19.9% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.67 | 22% |
| MSCI EAFE | 0.60 | 28% |
| MSCI Emg Mkts | 0.41 | 23% |
Liquidity Measures
| Avg. volume (000) | 79 |
| ADV traded (mns) | $1 |
| Turnover | 0.1% |
| Avg. Bid/Ask (% of price) | 0.00% |
Technical Indicators
| 30d moving avg. (EMA) | $8.73 |
| Relative strength (RSI) | 55 |
| MACD/Signal | 0.04/-0.01 |
| Bollinger Bands (Upper/Lower) | $8.94/$8.44 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. HEAL.L |
Expenses vs. HEAL.L |
ALTAR Score™ vs. HEAL.L |
|---|---|---|---|---|
| XDWH.DE | Xtrackers MSCI World Health Care UCITS ETF 1C | 29.0% | -15 bp | +4.5% |
| XDG3.DE | Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C | 27.4% | -5 bp | +4.1% |
| WHCA.L | iShares MSCI World Health Care Sector Advanced UCITS ETF | 27.4% | -22 bp | +4.2% |
| WHCS.AS | iShares MSCI World Health Care Sector Advanced UCITS ETF | 27.4% | -22 bp | +4.3% |
| XUHC.DE | Xtrackers MSCI USA Health Care UCITS ETF 1D | 25.3% | -28 bp | +4.5% |
| XUHL.DE | Xtrackers MSCI USA Health Care UCITS ETF 1C | 25.3% | -28 bp | +4.6% |
| IUHC.L | iShares S&P 500 Health Care Sector UCITS ETF | 25.2% | -25 bp | +4.7% |
| IUHE.AS | iShares S&P 500 Health Care Sector UCITS ETF | 25.2% | -22 bp | +4.8% |
| WELS.DE | Amundi S&P World Health Care Screened UCITS ETF Acc | 24.5% | -22 bp | +4.3% |
| WELG.DE | Amundi S&P World Health Care Screened UCITS ETF Dist | 24.5% | -22 bp | +4.2% |
Risk and Returns: HEAL.L vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 6/3/2026
Peer Group Comparison
Sample data. Subscribe for access.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
2.6%
ALTAR SCORE™
25th
PERCENTILE
UNDERWEIGHT
ETFRC RATING
There are 727 funds in the Global Equity category with an average
ALTAR Score™ of 4.3% and a standard deviation
of 2.6%. HEAL.L's ALTAR Score™ is approximately -0.7 standard
deviations above the category average. This places HEAL.L in the 25th percentile
among funds in the category.
Sell-Side Consensus
$10.85
PRICE TARGET
+24.1%
UPSIDE